Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SIGA TechnologiesSIGA 66 Gross Margin % is 52.89% as of Mar. 2026, which is 39% below its 10-year median of 87.42. GuruFocus rates SIGA with a GF Score™ of 66/100 and a GF Value™ of $4.49 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 941 Drug Manufacturers companies, SIGA Technologies ranks better than 76.83% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
SIGA Technologies had a gross margin of 52.89% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
SIGA Technologies Gross Margin % Related Terms
SIGA Technologies Gross Margin % Historical Data
* Premium members only.
The historical data trend for SIGA Technologies's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SIGA vs AKBA, TKNO, ORGO: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, SIGA Technologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SIGA Technologies Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, SIGA Technologies's Gross Margin % distribution charts can be found below:
* The bar in red indicates where SIGA Technologies's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
SIGA Technologies (SIGA) has a Gross Margin % of 52.89% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on SIGA Technologies and its competitors. This is 39% below median its historical median of 87.42. Over the past decade, SIGA Technologies' Gross Margin % has ranged from 65.36 to 93.33. According to the industry distribution chart, SIGA Technologies ranks #218 out of 941 companies in the Drug Manufacturers industry, placing it in the top 23.2%.
Is SIGA Technologies' Gross Margin % too high?
SIGA Technologies' current Gross Margin % of 52.89% is 39% below median its 10-year median of 87.42. Over the past 10 years, this metric has ranged from a low of 65.36 to a high of 93.33. The Drug Manufacturers industry median Gross Margin % is 48.54. SIGA Technologies' value of 52.89% is 9% above this industry median. Based on the distribution chart, SIGA Technologies ranks #218 out of 941 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, SIGA Technologies has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SIGA Technologies' Gross Margin % compare to AKBA and TKNO?
According to the Drug Manufacturers industry distribution chart, SIGA Technologies ranks #218 out of 941 companies for Gross Margin %. This places SIGA Technologies in the top 23% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 48.54. SIGA Technologies' value of 52.89% is 9% above this benchmark. Historically, SIGA Technologies' own Gross Margin % has ranged from 65.36 to 93.33 over the past decade. While the company's 10-year median is 87.42 vs. the industry median of 48.54, SIGA Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 941 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SIGA Technologies's current Gross Margin % of 52.89% is 9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on SIGA Technologies and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SIGA Technologies's current Gross Margin % is 52.89%, which is 39% below median its own 10-year median of 87.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SIGA Technologies stock overvalued right now?
Based on GuruFocus' analysis, SIGA Technologies (SIGA) is currently considered Modestly Undervalued. The stock's GF Value™ is $4.49, compared to a current price of $3.49 — trading 22.3% below its estimated fair value. The current Gross Margin % is 52.89%, which is 39% below median its 10-year median of 87.42 and 9% above the Drug Manufacturers industry median of 48.54. SIGA Technologies' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For SIGA Technologies (SIGA), the current Gross Margin % is 52.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SIGA Technologies (SIGA) Overvalued in 2026?
Based on GuruFocus' analysis, SIGA Technologies stock appears to be undervalued.
The current stock price of $3.49 is trading 22.3% below its estimated GF Value™ of $4.49.
GuruFocus considers SIGA Technologies to be Modestly Undervalued.
Key valuation signals for SIGA:
Gross Margin %: 52.89% (39% below median its 10-year median of 87.42)
GF Value™: $4.49 vs. price of $3.49 (22.3% below fair value)
Industry Position: 9% above the Drug Manufacturers median (#218 of 941)
No single metric tells the full story. See the SIGA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
66GF Score
Get the complete analysis for SIGA
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SIGA has been successfully added to your 
